Can low total IgG weaken antibody-mediated defense against infection?

Low total IgG (hypogammaglobulinemia) can meaningfully weaken humoral immune defense and contribute to recurrent or persistent infection susceptibility, especially when reduction is persistent or substantial and antibody function is impaired.

Clinical evidence

• The characteristic clinical phenotype is recurrent or severe bacterial sinopulmonary infection, particularly from encapsulated respiratory organisms such as Streptococcus pneumoniae and nontypeable Haemophilus influenzae.
• Risk is not determined by total IgG alone. It is most clinically apparent with markedly low or persistently low concentrations, recurrent/severe infections, and inadequate vaccine-antibody responses. Secondary hypogammaglobulinemia is commonly defined as IgG <700 mg/dL, while guidance often considers replacement when IgG is <400 mg/dL with recurrent, severe, persistent, or atypical infections; some use <500 mg/dL with recurrent severe bacterial infection and impaired pneumococcal responses.
• In rituximab-treated and other secondary-immunodeficiency cohorts, low baseline or persistent IgG has predicted serious infection; immunoglobulin replacement has been associated with fewer severe infections.

Mechanistic basis

• Antigen-specific IgG neutralizes microbial attachment, cell entry, and toxins.
• IgG-coated pathogens are cleared through Fcγ receptor–dependent phagocytosis. IgG1 and IgG3 can also activate the classical complement pathway, enhancing opsonization and antimicrobial inflammation. Reduced IgG quantity or pathogen-specific antibody function can therefore impair several complementary clearance pathways.

Clinical interpretation

• A low measurement warrants interpretation alongside infection history, medication and comorbidity review, protein-loss assessment, and antibody testing before and after protein and pneumococcal-polysaccharide vaccination. Malignancy, immunosuppressive treatment, lymphocyte depletion, HIV, graft-versus-host disease, structural lung disease, and protein loss can independently increase infection risk.

Bottom line

• Low total IgG is a well-supported contributor to impaired antibody-mediated protection and recurrent bacterial infection, but its practical significance depends on severity and persistence of deficiency, infection phenotype, functional antibody responses, and coexisting immune or structural risk factors.